Evidence map›Paper›PMID 27247465›Full record

Observational studyThe Canadian veterinary journal = La revue veterinaire canadienne2016

Evaluation of cardiac troponin I in dogs presenting to the emergency room using a point-of-care assay.

Adam Porter, Elizabeth Rozanski, Lori Lyn Price, Scott Shaw

Abstract readObservational Study
In one paragraph

Observational study in The Canadian veterinary journal = La revue veterinaire canadienne, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adam PorterNew England Veterinary Center and Cancer Care, 955 Kennedy Road, Windsor, Connecticut 06095, USA (Porter); Cummings School of Veterinary Medicine - Clinical Sciences, North Grafton, Massachusetts, USA (Rozanski); Tufts Medical Center, Boston, Massachusetts, USA (Price); VCA, Oxford, Massachusetts, USA (Shaw).
Elizabeth RozanskiNew England Veterinary Center and Cancer Care, 955 Kennedy Road, Windsor, Connecticut 06095, USA (Porter); Cummings School of Veterinary Medicine - Clinical Sciences, North Grafton, Massachusetts, USA (Rozanski); Tufts Medical Center, Boston, Massachusetts, USA (Price); VCA, Oxford, Massachusetts, USA (Shaw).
Lori Lyn PriceNew England Veterinary Center and Cancer Care, 955 Kennedy Road, Windsor, Connecticut 06095, USA (Porter); Cummings School of Veterinary Medicine - Clinical Sciences, North Grafton, Massachusetts, USA (Rozanski); Tufts Medical Center, Boston, Massachusetts, USA (Price); VCA, Oxford, Massachusetts, USA (Shaw).
Scott ShawNew England Veterinary Center and Cancer Care, 955 Kennedy Road, Windsor, Connecticut 06095, USA (Porter); Cummings School of Veterinary Medicine - Clinical Sciences, North Grafton, Massachusetts, USA (Rozanski); Tufts Medical Center, Boston, Massachusetts, USA (Price); VCA, Oxford, Massachusetts, USA (Shaw).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We used a point-of-care assay to evaluate cardiac troponin I (cTnI) in clinically normal dogs and a heterogeneous population of dogs presenting to the emergency room (ER) and to determine whether cTnI has prognostic capabilities in an ER population. Fourteen clinically normal dogs and 129 dogs presented to the ER were evaluated. Of the study group, 88 dogs had normal cTnI (< 0.1 ng/mL), 29 had elevated cTnI (0.1 to 1.0 ng/mL), and 12 had high cTnI (> 1.0 ng/mL). Dogs with elevated cTnI had 8 times the odds of mortality compared to dogs with normal cTnI [odds ratio (OR): 8.2, 95% confidence interval (CI): 3.0, 22.3]. Dogs with high cTnI had 17 times higher odds of mortality compared to dogs with normal cTnI (OR: 17.6, 95% CI: 4.4, 70.1). We conclude that cTnI shows promise as a prognostic indicator for dogs presenting to the ER and can be easily evaluated using a point-of-care assay.

Indexed as

AnimalsDog DiseasesDogsEmergency TreatmentFemaleMalePoint-of-Care SystemsPrognosisProspective StudiesTroponin ITroponin I

Identifiers

PMID27247465
PMCPMC4866670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.